4891.T
TMS Co.,Ltd.
グロース · 医薬品 · 医薬品 · JP
JPY 136.00
−4.23%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- +8.3%
- EPS
- +42.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- +23.0%
- EBIT
- +23.3%
- Net income
- -8.5%
- EPS
- +1.8%
- Free cash flow
- -49.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026